Valuation: Tellgen Corporation

Market Cap 1.95B 287M 251M 231M 215M 407M 27.24B 414M 2.78B 1.08B 13.44B 1.08B 1.05B 46.47B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 1.74B 256M 224M 207M 191M 363M 24.3B 369M 2.48B 963M 11.99B 961M 941M 41.46B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.27%
Yield 2024
1.06%
Yield 2025 0.54%
1 day-4.61%
1 week+0.41%
Current month+3.39%
1 month-9.02%
3 months-25.15%
6 months-37.18%
Current year-33.66%
1 week 11.7
Extreme 11.7
13.08
1 month 11.4
Extreme 11.4
13.57
Current year 11.4
Extreme 11.4
22.87
1 year 11.4
Extreme 11.4
32.8
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
46.57
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 2003-11-05
Director of Finance/CFO 50 2023-06-08
Chief Tech/Sci/R&D Officer 45 2020-12-08
Director TitleAgeSince
Chairman 56 2003-11-05
Director/Board Member 63 2019-08-13
Director/Board Member 44 2020-12-08
Change 5-day change 1-year change 3-year change Capi.($)
-4.61%+0.41%-18.29%-38.97% 301M
-1.73%+9.17%+230.63%+340.43% 22.39B
+1.44%+2.69%-40.81%-22.39% 9.37B
+3.36%-7.51%+29.57%+24.53% 6.69B
-5.42%-2.22%-34.32% - 5.03B
-3.71%-8.26%-27.41%-35.76% 4.74B
-5.62%-0.97%+218.54%-29.55% 5.08B
-4.50%-1.12%-24.96%-26.78% 4.25B
-5.61%-10.59%+63.61%+72.24% 3.9B
-2.02%+2.01%-18.84%-40.86% 2.62B
Average -2.94%-1.67%+37.77%+26.99% 6.44B
Weighted average by Cap. -2.43%+1.60%+91.25%+123.13%

Financials

2024 2025
Net sales 437M 64.28M 56.25M 51.84M 48.05M 91.22M 6.1B 92.69M 622M 242M 3.01B 241M 236M 10.41B 364M 53.54M 46.86M 43.18M 40.02M 75.98M 5.08B 77.2M 518M 201M 2.51B 201M 197M 8.67B
Net income 34.53M 5.08M 4.45M 4.1M 3.8M 7.21M 482M 7.33M 49.15M 19.11M 238M 19.08M 18.67M 823M 3.59M 528K 462K 426K 395K 749K 50.11M 761K 5.11M 1.99M 24.73M 1.98M 1.94M 85.49M
Net Debt -434M -63.91M -55.92M -51.54M -47.77M -90.68M -6.07B -92.15M -618M -240M -2.99B -240M -235M -10.35B -210M -30.96M -27.09M -24.97M -23.14M -43.93M -2.94B -44.63M -299M -116M -1.45B -116M -114M -5.01B
Logo Tellgen Corporation
Tellgen Corp is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
26-07-06 CN¥12.20 -4.61% 3,335,900
26-07-06 CN¥12.79 -1.24% 3,837,612
26-07-03 CN¥12.95 +3.11% 4,513,700
26-07-02 CN¥12.56 -0.24% 4,378,150
26-07-01 CN¥12.59 +6.69% 6,779,880

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock